I'd reccomend looking to exit from biotech longs before news this week. The resistance level between 290.75 and 293.47 is quite significant, and the forecasted target from my previous chart is almost hit. Anything above that target is a really decent exit for now.
The market being sideways, is what would frustrate the most people, and thus, it's the most likely scenario here, in the short term.
I'll be focusing on riding the short term legs via SPX, while holding my longer term fundamentally biased trades, heding my exposure to longs by selling calls when viable, and/or buying puts, whilst also being able to quickly switch from long to short SPX cfds, and generating uncorrelated returns from FX and commodity trades.
Good luck!
Ivan Labrie.
The market being sideways, is what would frustrate the most people, and thus, it's the most likely scenario here, in the short term.
I'll be focusing on riding the short term legs via SPX, while holding my longer term fundamentally biased trades, heding my exposure to longs by selling calls when viable, and/or buying puts, whilst also being able to quickly switch from long to short SPX cfds, and generating uncorrelated returns from FX and commodity trades.
Good luck!
Ivan Labrie.
Nota
Today's action is extremely positive. Breaking the high on 2016-08-04 is what I want to see next.
Public, timestamped track record. Free month of the desk: ivanlabrie.netlify.app
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Public, timestamped track record. Free month of the desk: ivanlabrie.netlify.app
Publicações relacionadas
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.